Nvidia Sinks

ESpeed declines; Hollywood Entertainment falls; plus more of Friday's stocks in the news

Nvidia (NVDA ) posted 3 cents, vs. 14 cents second-quarter EPS on a slight revenue drop. The maker of integrated graphics chipsets says the desktop graphics-processing unit segment declined significantly due to "unusual" market events. Wedbush Morgan downgraded to hold from buy. CIBC World and Schwab SoundView cut its estimates.

ESpeed (ESPD ) posted 16 cents, vs. 15 cents second-quarter earnings per share (GAAP) on a 9.5% revenue rise. It sees third-quarter earnings per share from operations of 9 cents to 10 cents. Jefferies downgraded to underperform from hold.

Hollywood Entertainment (HLYW ) says Leonard Green & Partners, its wholly owned subsidiary (the entities with which Hollywood Entertainment entered into a merger agreement on March 29, 2004), believes the financing condition to complete the merger will not be satisfied.

Chiquita Brands (CQB ) posted 73 cents, vs. $1.41 second-quarter earnings per share as charges in the current quarter, absence of gains vs. a year ago, offset a 2.3% sales rise.

Elizabeth Arden (RDEN ) posted a 35-cent second-quarter loss, vs. a 90-cent loss on a 17% revenue rise. The beauty company sees $900 million to $910 million in fiscal 2005 sales and $1.24 to $1.28 earnings per share.

WebMD (HLTH ) posted 2 cents, vs. 2 cents second-quarter earnings per share from continuing operations despite a 21% revenue rise. The medical-information Website sees 12 cents to 13 cents 2004 earnings per share on revenue of $1.145 billion to $1.155 billion. It says it will explore alternatives for its WebMD Health business.

Dov Pharmaceuticals (DOVP ) inked a deal with Merck (MRK ) to develop and commercialize Dov's novel triple uptake inhibitors for depression and related psychiatric disorders. The company will get a $35 million up-front payment.

MCI (MCIP ) posted a narrower-than-expected 22-cent second-quarter loss on a 15% revenue decline. The board declared excess cash of $2.2 billion, and initiated return of capital in the form of a quarterly dividend of 40 cents per share, payable Sept. 15.

Microvision (MVIS ) posted a 40-cent second-quarter loss, vs. a 38-cent loss on a 47% revenue decline, citing production and contract delays.

Gen-Probe (GPRO ) posted 23 cents, vs. 17 cents second-quarter earnings per share on a 21% revenue rise, and raised the 2004 earnings per share guidance to 97 cents to $1.00.

O'Charley's (CHUX ) posted 23 cents, vs. 27 cents second-quarter earnings per share on a 12% revenue rise. The restaurant operator estimated that increased commodity costs reduced earnings per share by about 8 cents, and it sees 20 cents to 22 cents third-quarter earnings per share.

Amgen 's (AMGN ) Aranesp received a positive regulatory opinion for extended dosing in the European Union.

Thoratec (THOR ) received FDA approval of its Pre-Market Approval Supplement to market the Thoratec implantable ventricular assist device, or IVAD, in the U.S.

Newfield Exploration (NFX ) acquired Inland Resources in a $575 million deal.

Old Dominion (ODFL ) sees 48 cents to 50 cents third-quarter earnings per share, and raised the 2004 earnings per share guidance to $1.55 to $1.59.

Ceridian (CEN ) will delay its Form 10-Q for the second quarter pending completion of an internal review focusing on capitalization and the expensing of certain costs in its U.S. Human Resource Solutions business.

Gemstar-TV Guide (GMST ) posted 10 cents second-quarter earnings per share from continuing operations, vs. a 7-cent loss as lower operating costs offset flat revenue.

Orasure Technologies (OSUR ) says the U.S. Substance Abuse and Mental Health Services Administration will purchase $4 million worth of its OraQuick Rapid HIV Antibody Tests and HIV confirmatory-test services.

Before it's here, it's on the Bloomberg Terminal.